Allchem Lifescience Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 4.25 Cr
as on 17-07-2024
- Company Age 8 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 192.33 Cr
as on 17-07-2024
- Satisfied Charges ₹ 87.48 Cr
as on 17-07-2024
- Revenue -1.26%
(FY 2023)
- Profit 34.35%
(FY 2023)
- Ebitda 27.49%
(FY 2023)
- Net Worth 73.50%
(FY 2023)
- Total Assets 52.54%
(FY 2023)
About Allchem Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.25 Cr.
The company currently has active open charges totaling ₹192.33 Cr. The company has closed loans amounting to ₹87.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bipin Patel and Kantilal Patel serve as directors at the Company.
- CIN/LLPIN
U24299GJ2017PTC095094
- Company No.
095094
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Allchem Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bipin Patel  | Managing Director | 12-Jan-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kantilal Patel | Director | 12-Jan-2017 | Current |
Financial Performance of Allchem Lifescience.
Allchem Lifescience Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.26% decrease. The company also saw a substantial improvement in profitability, with a 34.35% increase in profit. The company's net worth Soared by an impressive increase of 73.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Allchem Lifescience?
In 2023, Allchem Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 May 2022 | ₹2.69 M | Open |
Hdfc Bank Limited Creation Date: 23 May 2022 | ₹1.21 M | Open |
Others Creation Date: 11 Jan 2022 | ₹95.97 Cr | Open |
How Many Employees Work at Allchem Lifescience?
Allchem Lifescience has a workforce of 266 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allchem Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allchem Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
